Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Color Atlas of Neurology

.pdf
Скачиваний:
201
Добавлен:
11.08.2013
Размер:
18.87 Mб
Скачать

 

 

Index

 

 

 

Galactosemia 386

Gilles de la Tourette syndrome

Hartnup disease 306

Galea aponeurotica 4

68

Head injury 267

Gamma-aminobutyric acid

Glasgow coma scale 378

assessment criteria 379

(GABA) 140, 300

Glatiramer acetate 220

classification 267

Gancyclovir 244

Glioblastoma 260, 261, 265,

complications 269, 379

Gangliocytoma 377

377

see also Trauma

Ganglioglioma 377

Glioma

Head, zones of 110, 111

anaplastic 377

butterfly 260

Headache 182–191, 373

Ganglioma, parasympathetic

mixed 377

brain tumors and 254, 255

258

Gliomatosis cerebri 260

cervical syndrome 188, 189

Ganglion(a)

Globus

upper 188

basal 24, 42, 210, 211

hystericus 102

chronic daily 182

connections 210, 211

pallidus 210

causes 373

hemorrhage 176

Glomeruli, olfactory 76

chronic paroxysmal

Parkinson disease and 210,

Glomus

hemicrania (CPH) 186, 190

211

carotid 150

cluster 186, 187, 190

dorsal root 2

tumor 377

chronic 186, 190

spinal 2

Glutamate 140, 210

episodic 186, 190

trigeminal

antagonists 212

pathogenesis 186

central connections 94, 95

Glutamate decarboxylase 300

combination 182

peripheral connections 94,

Glycerol 264

diagnostic classification 191

95

Glycogen storage disease 340

ice-pick 182

varicella-zoster and 238

Goiter 311

intracranial hypertension

Ganglioneuropathy 390

Gonadotropins 143

and 158

Ganglionitis 238

Gordon reflex 40

intracranial hypotension and

Gangliosidosis

Granulomatosis

160

GM1 307, 387

lymphomatoid 180

migraine 184–185, 190, 373

GM2 307

Wegener 180

symptoms and signs 184

Ganser syndrome 138

Growth hormones 143, 367

aura 184, 185

Gastrointestinal function 154–

GH-secreting tumors 258

headache phase 184

155

Guillain–Barré syndrome 244,

prodromal phase 184

neurological causes of dys-

326–327, 395

resolution phase 184

function 370

clinical spectrum 395

nociceptive transmission

Gastroparesis 370

diagnosis 326, 396

188, 189

Gaucher disease 306, 307,

pathogenesis 326

posttraumatic 270, 271

387

symptoms and signs 326

prophylaxis 190

Gaze deviation

treatment 326

sinus 186, 187

contralateral 86

Gustatory pathway 78

substance-induced 188, 189

skew 70, 89

Gyrus(i)

acute 188

Gaze palsy 88

angular 124

rebound 188

contralateral 86

cingulate 144

tension 182, 183

ipsilateral 86

dentate 144

chronic 182, 190, 373

Parkinson disease 208

postcentral 12

episodic 182, 190

progressive supranuclear

precentral 12

pathogenesis 182

palsy 303

 

treatment 182, 190

Genetic predisposition

H

trigeminal neuralgia 186,

epilepsy 198

187, 190

Haemophilus influenzae 376

Parkinson disease 213

idiopathic 186

spongiform ence-

chemoprophylaxis 226

pathogenesis 186

phalopathies 252

vaccination 226

symptomatic 186

Genotype 288, 289

Hair cells 100

vascular processes and 166,

Germinoma 258, 377

Hallucinations

182, 183

Gerstmann syndrome 128

olfactory 76

subarachnoid hemorrhage

Gerstmann–Sträussler–

Parkinson disease 208

176

Scheinker syndrome 280

Haloperidol 204

Hearing 100–101

Giant axon neuropathy 397

Hand grip test 369

age-related changes 382

Gibberish, fluent 124

Hangover 188

sound perception 100

Index

423

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Index

424

Index

Heart 148–149

diagnosis 288

pathogenesis 240, 241

Heel–knee–shin test 276

inheritance 288, 289

primary infection 240

Heerfordt syndrome 362

mutations 288

secondary complications

Helicotrema 100

phenotype 288

240

Hemangioblastoma 256, 257

see also specific diseases

symptoms and signs 240

Hemangioma 294

Hereditary hemorrhagic tel-

Huntington 300

Hemangiopericytoma 377

angiectasia (HHT) 294

Huntington disease 66, 300,

Hematoma 268

Hereditary motor–sensory

301

epidural 268, 270

neuropathy (HMSN) 332,

inheritance 300

intracerebral 270

333, 396

anticipation 300

intraparenchymal 268

type I 332, 333, 396

pathogenesis 300

posttraumatic 267

type II 332, 396

symptoms and signs 300

subarachnoid 268

type III 332, 396

Westphal variant 300

subdural 268, 270

Hereditary neuropathy with

Hydranencephaly 290, 381

chronic 379

pressure palsies (HNPP) 332,

Hydrocephalus 161–163, 290,

Hemianopsia 82

333

291, 366, 379, 381

heteronymous 82

Hering–Breuer reflex 150

acute 162, 290

homonymous, altitudinal 82

Herniation

brain edema 162–163

Hemiballism 66–67

intervertebral disk 318, 319,

chronic 162

Hemicrania, chronic paroxys-

392

communicating/malresorp-

mal (CPH) 186, 190

intracranial hypertension

tive 162

Hemineglect 132

and 158, 159, 162

congenital 290

Hemiparesis 47, 122

subfalcine 162

external 162

contralateral 46, 158

transtentorial 118, 158

non-communicating/ob-

Hemiplegia 122

Herpes labialis 236

structive 162, 258, 290

alternans 46

Herpes simplex 236–237, 376

normal-pressure 160, 161,

Hemodynamic abnormalities

pathogenesis 236

162

148, 174

symptoms and signs 236

subarachnoid hemorrhage

Hemorrhage 166, 176–179

treatment 236

and 176

intracerebral 166, 167, 176

type 1 (HSV-1) 236, 237

symptoms and signs 290

basal ganglia 176

type 2 (HSV-2) 236

treatment 290

brain stem 176

Herpes zoster 180, 238, 239

Hydrochlorothiazide 338

caudate 176

occipitocollaris 238

Hydrophobia 246, 247

cerebellar 176

ophthalmicus 238

Hydroxocobalamin 286

complications 176

oticus 238

Hygroma, subdural 379

lobar 176

sine herpete 238

Hyperalgesia 316

massive hypertensive 178

symptoms and signs 238

Hyperammonemia 386

pathogenesis 178

Hiccups 68

Hypercalcemia 310

pontine 176

Hippocampus 144, 145

Hypercapnia 308

putaminal 176

Histiocytoma, malignant

Hypereosinophilia syndrome

thalamic 176

fibrous 260

344

treatment 178

History taking 350

Hyperesthesia 316

intraventricular 166, 176,

Holmes tremor 357

Hyperglycemia 308, 324

177, 270

Homocystinuria 307

hyperosmolar nonketonic

complications 176

Hormones

308

symptoms and signs 176

aglandotropic 142

Hyperglycinemia, nonketonic

spinal 282

glandotropic 142

386

subarachnoid 166, 176–177,

growth 143

Hyperhidrosis, Parkinson dis-

270

thyroid 143

ease and 208

complications 176

see also specific hormones

Hyperkalemia 52, 338, 401

pathogenesis 178

Horner syndrome 48, 92, 152,

Hyperkinesia 383

symptoms and signs 176

318

Hypermetria 70

treatment 178

central 92

Hyperprolactinemia 258

see also Stroke

Hospital hopper 138

Hypersomnia 114, 116

Hepatic encephalopathy 308,

Human immunodeficiency

Hypertension 148

309, 387

virus (HIV) 240–241, 376

intracerebral hemorrhage

Hereditary diseases 288

antiretroviral therapy 240

and 178

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Index

intracranial 158–160, 224, 268, 290

causes 371 treatment 264, 270

Hyperthermia central 152 malignant 346–347

Hypertrophy, muscular 334, 338, 397

Hyperventilation syndrome 204, 205, 370

Hypervolemia 310

Hypesthesia 106

Hypocalcemia 310 Hypochondriacal disorder 138,

139 Hypogeusia 78

Hypoglycemia 308, 309, 324 acute 308

chronic 308 subacute 308

Hypokalemia 52, 338 Hypokinesia 206 Hypomagnesemia 310 Hypometria 70 Hypomimia 206, 207, 362 Hypoperfusion 174 Hypophonia 206 Hyposmia 76 Hypotension 148, 268

antiparkinsonian medications and 208

idiopathic orthostatic 302 intracranial 160–161

causes 372 Hypothalamic–pituitary regu-

latory axis 367 Hypothalamus 24, 140, 142–

143 functions 142

fluid balance 310 thermoregulation 152

neuroendocrine control 142, 143

pain and 108 Hypothermia 152 Hypothyroidism 311 Hypoventilation 370 Hypovolemia 310 Hypoxia 268

global cerebral 172 hypoxic–ischemic ence-

phalopathy 308, 309

I

Iatrogenic encephalopathy 314, 315, 389

Idiopathic

cerebellar ataxia (IDCA) 276 orthostatic hypotension 302 Parkinson disease 302 torsion dystonia 64 trigeminal neuralgia 186

Immunization see Vaccination Incisura, tentorial 6

Inclusion body myositis 52, 252, 344, 345

Incontinence fecal 216, 370

urinary see Bladder dysfunction

Incus 100

Infantile cerebral palsy see Cerebral palsy

Infarction 172, 174

anterior cerebral artery 168 anterior choroidal artery 168 border zone 168, 172, 173 cerebellar arteries 170 dementia and 298

multi-infarct dementia 298

strategic infarct dementia 298

dorsolateral 170 end zone 172, 173 hemodynamic 172

internal carotid artery 168, 169

border zone 168 territorial 168

lacunar 168, 172 low-flow 172 paramedian 170 pontine 170 spinal

central 282 complete 282

territorial 168, 172, 173, 224 hemorrhagic conversion

172 threshold 174 types of 172

Infections see Central nervous system (CNS); specific

infections

Inflammatory response 224 multiple sclerosis 220 tuberculous meningitis 232

Infundibulum 6

Inheritance 288, 289 monogenic 288 multifactorial 288 polygenic 288 Innervation ratio 44

Insomnia 114

fatal familial 114, 280 psychogenic 114

Inspiration 150

Interoceptors 104 Intervertebral disks 30 Intestine

colon 154 pseudo-obstruction 370 small 154

Intoxication 312, 313 Intracranial pressure (ICP)

158–163

brain tumors and 254 compliance 162 elastance 162

hypertension 158–160, 268, 290

causes 371

clinical features 158–160 treatment 264, 270

hypotension 160–161 causes 372 symptoms 160

pathogenesis 162 Introns 288 Involution 296

Iodine–starch (Minor) test 152 Iris 90

Ischemia 166, 268 cerebral 148 delayed 176 global 172

hypoxic–ischemic encephalopathy 308, 309

threshold 174

transient ischemic attack (TIA) 166

see also Stroke Ischemic penumbra 174 Isocortex 24

Isoniazid 232 Itraconazole 248

J

Jaw jerk reflex 26 JC virus 244

Jefferson’s fracture 380 Jet lag 114

Joints, Charcot 230 Jugum sphenoidale 4

Index

425

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Index

426

Index

K

Karnofsky scale 26, 378 Kearns–Sayre syndrome (KSS)

403 Keratoconjunctivitis 236 Kernig’s sign 222

King–Denborough syndrome 347

Klippel–Feil syndrome 292, 293

Klumpke–Dejerine palsy 318 Korsakoff syndrome 76, 308,

312

Krabbe disease 307, 332, 387 Kufs disease 307

Kussmaul’s respiration 118

L

Labyrinth 56 Lacrimation, test of 98 Lacunar state 172, 173 Lacunes 172, 298

Lambert–Eaton myasthenic syndrome (LEMS) 50, 52, 342, 343, 406

Lamotrigine 198 Lance–Adams syndrome 308 Language 124–125

aphasia 124, 126–127 model 124

Larynx, voice production 130 Lasègue’s sign 318 Laterocollis 64

Lathyrism 286, 304, 384 Law of Bell and Magendie 30 Leigh disease 306

maternally-inherited (MILS) 403

Lemniscus, trigeminal 94 Lennox–Gastaut syndrome

196, 198

Lens accommodation 90 Leprosy 328, 329 Leptomeninges 6

metastases 262, 263 treatment 265

Leukoaraiosis 298

Leukodystrophy globoid cell 387

metachromatic 306, 307, 332, 333

Leukoencephalitis 234 Levetiracetam 198 Levodopa 208, 212

adverse effects 389

Levomepromazine 264 Lewy bodies 208, 210, 302 Lhermitte’s sign 48, 49, 214 Life expectancy 296

active 296 Lifespan 296

Ligament, denticulate 30 Light reflex 90, 91 Light–near dissociation 92 Limb girdle dystrophy 336,

337, 400

Limbic system 80, 135, 144– 145

functions 144 nerve pathways 144 pain and 108 structure 144, 145 syndromes 368

Lipid metabolism disorders 332, 333

Lissencephaly 381

Listeria 376

Lisuride 212 Lobe

frontal hemorrhage 176 lesions 122

left 122 right 122

occipital, hemorrhage 176 parietal, hemorrhage 176 temporal, hemorrhage 176 Locked-in syndrome 120, 121,

170, 359 LSD abuse 314

Lumbar puncture 2, 407 intracranial hypotension and

160

multiple sclerosis and 218, 219

Lungs 150

Lyme disease 228–229 chronic 228

clinical manifestations 228, 229

diagnosis 228 pathogenesis 228 treatment 228

Lymphadenosis benigna cutis 228

Lymphoma 180, 377, 385 cerebral, primary 260, 261,

265

ocular manifestations 260 non-Hodgkin 260, 261

M

McLeod syndrome 300 Macroadenoma 258 Macrocephaly 290, 381 Macrographia 276 Macrophages 220 Maculae 56

saccular 56 utricular 56

Magnesium balance 310 Magnetic resonance imaging

(MRI) 354

brain tumors 260, 264–265 multiple sclerosis 218, 219 Major histocompatibility com-

plex (MHC) 220

Malaise, brain tumors and 254 Malaria, cerebral 250, 251 Malformations 288, 381

Chiari 292, 293 Dandy–Walker 292

Malignancy see Brain tumors; specific tumors

Malignant hyperthermia 346– 347

Malignant neuroleptic syndrome 208, 347

Malingering 138 Malleus 100 Mannitol 264

Maple syrup urine disease 386 Marcus–Gunn pupils 214 MDMA abuse 314

Mean arterial pressure (MAP) 162, 174

Mechanoreceptors 104, 150 Medulla, adrenal 140 Medulla oblongata 2, 26

caudal 148 lesions 70 rostral 148

syndromes 70, 73, 361 dorsolateral 361 Medulloblastoma 260, 261,

265 Megalencephaly 381

Meige syndrome 64, 362 Melkersson–Rosenthal syn-

drome 362 Melperone 264 Membrane(s) arachnoid 6

spinal 30 basilar 100 tympanic 100 Memory 134–135

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

 

 

Index

 

 

 

 

declarative (explicit) 134, 135

viral 234–235

Monoparesis 46, 47

disorders 134, 368

herpes zoster 238

Monoradiculopathy 316, 318

Alzheimer disease 297

pathogens 234

lumbar 318

head trauma and 269

Meningopolyradiculitis 230

Monto–Kelli doctrine 162

Parkinson disease 208

Mental retardation 381

Motor end plate 2

episodic 134

Mesencephalon 2, 26

lesions 50

examination 134, 353

Metachromatic leukodystrophy

Motor evoked potentials (MEP)

long-term 134

306, 307, 332, 333

218, 352

 

nondeclarative (implicit)

Metastatic disease 262–263

Motor function

134, 135

cascade hypothesis 262

age-related changes 382

semantic 134

drop metastasis 260, 262

Parkinson disease and 210

short-term 134

intracranial 262, 263, 265

Motor neuron diseases 304–

Ménière’s disease 58

spinal 262, 263, 265

305, 384–386

Meningeosis, neoplastic 262

treatment 265

lower 50, 304, 385, 386

Meninges 6–7

Methotrexate 220

treatment 304

Meningioma 256, 257, 377

Methylprednisolone 220, 238

upper 46, 304, 384, 386

anaplastic 377

Metoclopramide 204

Motor unit 44

extracranial 256

Mexiletine 338

Movements

familial 256

Microadenoma 258

mass 46

treatment 264

Microaneurysm 179

periodic leg 114

Meningism 222

Microangiopathy 172

reflex 42

Meningitis 222, 268

Microcephaly 381

respiratory 150, 151

aseptic 234, 236, 242

Microglia 220

rhythmic 42

postinfectious 234

Micrographia 128, 206, 207

spontaneous 50

postvaccinal 234

Micturition 156

coma staging 118

asymptomatic 230

Migraine 184–185, 373

voluntary 42

bacterial 180, 226, 376

pathogenesis 184

see also Dyskinesia(s);

borrelia-related (Lyme)

symptoms and signs 184

Dystonia; Eye movements;

228

aura 184, 185

Tics; Tremor

tuberculous 232–233

headache phase 184

Mucor (mucormycosis) 248

pathogenesis 232

prodromal phase 184

rhinocerebral 248, 249

symptoms and signs

resolution phase 184

Multi-infarct dementia 298

232, 233

treatment 190

Multifocal motor neuropathy

treatment 232

Migration disorder 381

(MMN) 328, 329

Candida and 248

Miller–Fisher syndrome 327,

Multiple organ failure 312

carcinomatous 262

395

Multiple sclerosis (MS) 214–221

chronic 232

Mini-Mental Status Examina-

clinical manifestations 214–

clinical manifestations 222

tion 136

217, 218, 219

 

Lyme disease and 228

Mini-syndrome test 136

autonomic dysfunction

Mollaret 234

Minor test 152

216, 217, 371

 

neurosyphilis and 230, 231

Miosis 90, 382

behavioral changes 216, 217

prophylaxis 226

unilateral 92

fatigue 214

viral 234, 376

Mitochondrial disorders 288,

incoordination 216, 217

pathogens 234

307, 398

pain 214

poliovirus 242

encephalopathy 281

paresis 214

Meningococcus 376

myopathy 52, 398, 403

paroxysmal phenomena

vaccination 226

Mitoxantrone 220

216, 217

 

Meningoencephalitis 222

Möbius syndrome 362

sensory disturbances 214,

arteritis and 226

Mollaret meningitis 234

215

 

bacterial 226, 376

Monoclonal gammopathy of

spasticity 214

Candida and 248

undetermined significance

visual impairment 214, 215

cryptococcosis and 248

(MGUS) 328

course of 214, 216

neurosyphilis and 230

Mononeuritis multiplex 240

benign 216

prophylaxis 226

Mononeuropathy 50, 180, 316,

chronic progressive 214

treatment 224

318, 322–323, 390, 394

malignant 216

guidelines 375

multiplex 316, 390

relapsing-remitting 214

tuberculous 232

see also Neuropathy

diagnostic criteria 375

Index

427

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Index

 

Multiple sclerosis (MS)

 

differential diagnosis 216

 

laboratory tests 218

 

bladder function 218

 

cerebrospinal fluid exami-

 

nation 218, 219

 

evoked potentials 218

 

neuroimaging 218, 219

 

pathogenesis 218–221

 

activation 220, 221

 

antigen presentation and

 

stimulation 220

 

demyelination 220

 

passage through blood–

 

brain barrier 220

 

scar formation 220

 

prognosis 216

 

rehabilitation 220

 

relapse 214, 220

 

remission 214

 

treatment 220

 

symptomatic therapy 220

Index

Multiple system atrophy

(MSA) 276, 302, 303

 

 

bladder dysfunction and 371

 

Mumps virus 376

 

Münchhausen syndrome 138

 

by proxy 138

 

Muscle phosphorylase defi-

 

ciency 402

 

Muscle(s)

 

atrophy 49–52, 107, 281, 287,

 

334, 406

 

peripheral neuropathy and

 

316

 

poliomyelitis and 242,

 

243

 

spinal (SMA) 385

 

spinobulbar 385

 

cramps 397

 

detrusor 156

 

expiratory, auxiliary 150,

 

151

 

facial, syndromes affecting

 

362

 

functional disorders 52

 

hypertrophy 334, 338, 397

 

levator palpebrae superioris

 

90

 

pain 52

 

see also Myalgia

 

respiratory 150

 

auxiliary 150

 

segment-indicating 32, 357

428spasms 334 stiffness 52, 334

tarsal, superior 90

tone 276

weakness 334, 374, 397, 405 see also Myopathy

Muscular dystrophies 336–337, 398, 400

Becker 336, 337, 400 diagnosis 336

Duchenne 52, 53, 336, 337, 400

Emery–Dreifuss 336, 337 facioscapulohumeral 337,

400

pathogenesis 336, 337 symptoms and signs 336 treatment 336

see also Dystrophy Mutation 288

chromosome 288 gene 288 genome 288 germ-line 288 somatic 288

Myalgia 52, 334, 346, 397 causes 346

toxic 405

Myasthenia gravis 52, 342– 343, 406

aggravating drugs 403 crises 404

diagnosis 342 ancillary tests 404

pathogenesis 342 symptoms and signs 342 treatment 342

Mycobacterium leprae 328

tuberculosis 232, 376 Mycosis, opportunistic sys-

temic 248

see also Fungal infections Mydriasis 90

unilateral 92 Myelin sheath 2

lesions, multiple sclerosis 220

Myelinolysis, central pontine 310, 315

alcoholism and 314 Myelinopathy 316 Myelitis 222, 282

clinical manifestations 222 Lyme disease and 228 treatment 286

viral 282, 376

herpes simplex 236 herpes zoster 238

Myelography 354

Myelomeningoradiculitis, tuberculous 232

Myelopathy 282–287 acute 282–283 cervical 284, 285 chronic 48, 284–284 diagnostic studies 286 hereditary 186

HIV 240

subacute 284–285

subacute combined degeneration (SCD) 286, 287

toxic 286, 287 treatment 286

Myoclonus 66–69, 383 epilepsy with ragged red

fibers (MERRF) 403 essential 68

myoclonic encephalopathies 68

physiological 68 progressive myoclonus

epilepsy with Lafora bodies 307

sleep 68, 114 symptomatic 68

Myokymia 50

Myopathy 50–52, 334–347, 397–405

carnitine deficiency 304, 402 causes 334

centronuclear 402 congenital 52, 340, 341, 398,

402

critical illness (CIM) 347, 379 diagnosis 334, 399 endocrine 347, 398

episodic paralyses 338, 339 hereditary 398 inflammatory 344, 398 malignant hyperthermia

346–347

metabolic 340, 341, 402 mitochondrial 52, 340, 341,

398, 403 myalgia 346

myasthenic syndromes 342– 343

myotonias 338, 339, 401 nemaline 402 paraneoplastic syndromes

347 primary 52

rhabdomyolysis 346 secondary 52 symptoms and signs 334 toxic 398, 405

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

 

 

Index

 

 

 

neuromuscular syndromes

Nerve palsy

mental 94

347, 398

abducens 86, 87

musculocutaneous 35

see also Muscular dystro-

facial 96, 98, 99

nasociliary 94

phies

Lyme disease 228, 229

obturator, mononeuropathy

Myopathy, encephalopathy,

oculomotor 86, 87, 92, 158

323

lactic acidosis and strokelike

trochlear 86, 87

oculomotor, palsy 86, 87, 92,

episodes (MELAS) 403

complete 86, 87

158, 325

Myositis 52, 344–345

incomplete 86

olfactory 2

diagnosis 344

Nerve roots

ophthalmic 94

inclusion body 52, 252, 344,

dorsal 2

optic 2, 372

345

spinal 30

atrophy 158, 159

infectious 344

root filaments 30

peripheral 2

Lyme disease and 228

trauma 272

peroneal 37

ossificans 379

avulsion 330

mononeuropathy 323, 394

pathogenesis 344

ventral 2

phrenic 150

syndromes 344

spinal 30

radial 35

toxoplasmosis and 250

Nerve(s)

mononeuropathy 322, 394

treatment 344

abducens, palsy 86, 87

sciatic 37

viral 52

alveolar

mononeuropathy 394

Myotomes 32, 33

inferior 94

spinal 2, 31, 32, 150

Myotonia 338, 339, 401, 405

superior 94

supraorbital 94

action 338

auriculotemporal 94

supratrochlear 94

congenital 52, 338, 339

axillary 35

sural, biopsy 391

Becker 401

mononeuropathy 322, 394

thoracic, long, mono-

Thomsen 401

buccal 94

neuropathy 322, 394

fluctuans 401

cochlear 100

tibial 37

paradoxical 338

cranial 2, 6, 28–29, 356

mononeuropathy 323, 394

pathogenesis 338

herpes zoster and 238

trigeminal 6, 76, 94–95

percussion 338

motor cranial nerve nuclei

dysfunction 98

symptoms and signs 338

130

mesencephalic nucleus 94

treatment 338

nerve pathways 26, 28

motor nucleus 94

Myotonic dystrophy 52, 338,

see also specific nerves

principal sensory nucleus

339, 400, 401

cutaneous, lateral, of the

94

 

thigh 37

spinal nucleus 94

N

mononeuropathy 323, 394

trochlear, palsy 86, 87

ethmoid

ulnar 35

 

Nacrolepsy 114

anterior 94

mononeuropathy 322, 394

Nasal cavity 4

posterior 94

vagus 6, 154

Natalizumab 220

facial 96–99

zygomatic 94

Nausea

functional systems 96

Neural tube defects 292, 293

brain tumors and 254, 255

lesions 98–99

Neuralgia 363

intracranial hypertension

examination 98

postherpetic 238

and 158, 159

palsy 96, 98, 99

trigeminal 186, 187, 190

Near response 90

nerve pathways 96

idiopathic 186

Neck stiffness, meningitis and

femoral 37

multiple sclerosis 214

222, 223

mononeuropathy 323, 394

pathogenesis 186

Necrosis 174

frontal 94

symptomatic 186

focal 224

gluteal, mononeuropathy

Neuralgic amyotrophy 321,

Needle electromyography 391,

323

328, 329

399

infraorbital 94

Neurapraxia 330, 331

Neocerebellum 54

lacrimal 94

Neurites, Lewy 210

Neologisms 124, 126

lingual 94

Neuritic plaques (NPs) 297

Nerve injuries 330, 331

mandibular 94

Neuritis

pathogenesis 330

maxillary 94

optic, multiple sclerosis 214,

compression 330

median 35

218

crushing injuries 330

mononeuropathy 322, 394

retrobulbar 214

transection 330

meningeal 94

toxoplasmosis and 250

Index

429

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Index

430

Index

Neuroacanthocytosis 300,

spinal

Neurotuberculosis 232

301

parasympathetic 140

Niemann–Pick disease 306,

Neuroblastoma 377

sympathetic 140

307, 387

Neuroborreliosis 228–229

Neuropathy

Nightmares 114

chronic 228

acquired 317, 390

Ninhydrin test 152

clinical manifestations 228,

acute motor-axonal (AMAN)

Nociception 108

229

395

see also Pain

diagnosis 228

acute motor-sensory axonal

Nodes of Ranvier 2

pathogenesis 228

(AMSAN) 395

Nonneurological disorders

treatment 228

amyloid 333

138–139

Neurocranium 4

diagnosis 316, 391

Norepinephrine 140, 382

Neurocybernetic prosthesis

giant axon 397

Notch, tentorial 6

(NCP) 198

hereditary 317, 390

Nucleus(i)

Neurocysticercosis 250, 251

peripheral 316–333

ambiguus 102, 148

Neurodegenerative diseases

diabetic 324, 325

caudate 210

296–305

hereditary 332–333

cochlear

aging 296

metabolic 332, 333

anterior 100

degenerative changes and

nonmetabolic 332, 333

posterior 100

296

infectious origin 328

cuneatus 104

disease and 296

inflammatory poly-

detrusor 156

see also specific diseases

neuropathies 326–329

Edinger–Westphal 26, 90

Neurofibrillary tangles (NFTs)

mononeuropathies 318,

gracilis 104

297

322–323, 390, 394

lentiform 210

Neurofibroma 294, 295

multifocal motor (MMN)

motor cranial nerve 130

Neurofibromatosis 294, 295

328, 329

oculomotor 90

symptoms and signs 294

nerve injuries 330–331

Onuf’s 156

type 1 (NF1) 294

pathogenesis 330

Perlia’s 90

type 2 (NF2) 258, 294

plexopathy 318

pulposus 30

Neurography 391, 399

radicular lesions 318, 320

red 24

Neurohypophysis 142

uremic 324

respiratory group

Neuroimaging 353–354, 391,

vasculitic 328, 329

dorsal 150

399

small fiber 316

ventral 150

brain tumors 254, 264–265

symptoms and signs 316

solitary tract 148

multiple sclerosis 218, 219

autonomic 316

subthalamic 24, 210

myasthenia gravis 404

motor dysfunction 316

tractus solitarius 102

Neuroleptics, adverse effects

sensory dysfunction 316

ventral posterolateral (VPL)

389, 403

syndromes 316–317, 390

104

acute dystonic reaction

tomaculous 332

vestibular 26, 56

204

Neuropeptides, pain reception

Nystagmus 70, 86, 88–89

malignant neuroleptic syn-

and 108

congenital 88

drome 208

Neuroprotective therapy 212

end-position 88

Neuroma, acoustic 258, 259,

Neurosyphilis 230–231

examination 88

294

clinical manifestations 230,

gaze-evoked 88, 89, 276, 277

Neuromodulators, autonomic

231

gaze-paretic 88

nervous system 140–141

early meningitis 230, 231

jerk 88

Neuromuscular junction 2

progressive paralysis 230,

multiple sclerosis 214, 215

lesions 50, 347, 398

231

optokinetic 84, 88

paraneoplastic syndromes

tabes dorsalis 230, 231

pathological 88

406

meningovascular 230

physiological 88

postpolio syndrome and

pathogenesis 230

positional 70, 88

242

treatment 230

see-saw 70

Neuromyotonia 52, 406

Neurotmesis 330, 331

spontaneous 88, 89

Neuronal ceroid lipofuscinosis

Neurotransmitters

vestibular

307

autonomic nervous system

central 88, 89

Neuronopathy 316, 390, 406

140–141

peripheral 88, 89

Neurons

pain reception and 108

 

medium spiny-type 210

Parkinson disease and 210

 

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Index

O

Obstructive sleep apnea 114 Occlusion 172

basilar artery 170, 171 brachiocephalic trunk 168 carotid artery

common 168 internal 168

cerebellar arteries 170, 171 cerebral artery

middle 168, 169 posterior 170, 171

lenticulostriate artery 168 ophthalmic artery 168 subclavian artery 170

Ocular deviation 70 Oculomotor disturbances

86–88, 276 examination 86

internuclear disturbances 86

peripheral disturbances 86 stroke and 166 supranuclear disturbances

86

Oculomotor function 84–85 Odynophagia 102 Olfaction 76–77

disturbances 76 tests of 76

Olfactory pathway 76 Oligoastrocytoma 256, 377

anaplastic 377 Oligodendroglioma 256, 377

anaplastic 260, 261, 377 One-and-a-half syndrome 86 Onuf’s nucleus 156 Ophthalmoplegia

chronic progressive external (CPEO) 403

internuclear 86, 87, 214 Ophthalmoscopy 80 Opiate abuse 314 Oppenheim reflex 40

Opportunistic infections 240 fungal 248–249

aspergillosis 248, 249 candidosis 248, 249 cryptococcosis 248, 249 mucormycosis 248, 249

Orbit 4, 372 Organ(s)

circumventricular 140 of Corti 100 subfornical 140

Organum vasculosum 140

Orientation evaluation 353 Orthostasis test 369 Osler–Weber–Rendu disease

294 Osmoregulation 310 Ossicles, auditory 100 Overlap syndrome 344 Oxcarbazepine 198 Oxidative stress 212

P

Pachygyria 381

Pachymeninges 6 Pain 108–111

classification of 363 complex regional pain syn-

drome (CRPS) 110 diabetic neuropathy and 324 dysesthesia 106

facial, atypical 373 multiple sclerosis 214 myelopathies 282

nerve pathways 104, 109 neurosyphilis 230 Parkinson disease 208, 209 pathogenesis 108 persistent somatoform pain

disorder 138, 139 processing 108, 109

neurotransmitter/neuropeptide role 108

pseudoradicular 32 radicular 32 reception 108 referred 108, 110, 363

headache 188, 189 sensitization

central 108 peripheral 108

transmission 108 treatment 264, 324 types of 108, 109, 363

central 363 chronic 363 deafferentation 363

neuropathic 108, 363 nociceptive 108, 363 phantom limb 363 psychogenic 363 radicular 363 somatic 108, 363 visceral 108, 110

zones of Head 110, 111 see also Myalgia

Paleocerebellum 54 Pallidotomy 212

Palsy

cerebral, infantile 288–291, 381

causes 288

symptoms and signs 288 treatment 290

Erb 318 Klumpke–Dejerine 318 progressive supranuclear

(PSP) 208, 302, 303 pseudobulbar 362 see also Nerve palsy

Pancoast tumor 262 Panic disorder 202, 203 Papez circuit 144 Papilledema 158, 159, 160

brain tumors and 254, 255 chronic 158, 159 meningitis and 222

Papilloma, choroid plexus 256, 257, 377

Paraganglioma 258 sympathetic 258

Paragrammatism 124, 126 Paralysis

central 46–49

upper motor neuron (UMN) lesions 46

crossed 46, 47, 70 episodic 338, 339, 401

diagnosis 338 pathogenesis 338 prophylaxis 338 symptoms and signs 338 treatment 338

peripheral 50–53 poliomyelitis and 242, 243 progressive, neurosyphilis

and 230, 231

spinal, familial spastic 286, 287

Paramyotonia cold-induced 52 congenita 338, 339, 401

Paraneoplastic syndromes 312, 347, 388

neuromuscular 406 Paraparesis 46

tropical spastic 384 Paraphasia 126

phonemic 124 semantic 124

Paraplegia

familial spastic (FSP) 286, 287, 384

in flexion 214

spinal cord trauma and 274

Index

431

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Index

432

Index

Parapraxia 128

stereotactic neurosurgical

Uhthoff’s 214

Paraproteinemic poly-

procedures 212

Phenotype 288, 289

neuropathy 328, 329, 406

symptomatic 212

Phenylketonuria 306

Parasomnias 114

transplant surgery 212

Phenytoin 198, 264

Parasympathetic nervous

visual disturbances 208

Pheochromocytoma 258

system 90, 140, 147, 148, 154

Parkinsonism 374, 383

Phonation 130

Paresis

atypical 302–303

dysphonia 130

crossed 47

Parosmia 76

Phosphofructokinase defi-

ipsilateral 46

Paroxysmal depolarization

ciency 402

Lyme disease and 228, 229

shift 198

Photoreceptors 104

multiple sclerosis 214

Pathway(s)

Physical examination 350–351

peripheral 47

auditory 100, 101

Pia mater 6

Paresthesia 106, 316

cranial nerves 26–28

spinal 30

multiple sclerosis 214

deglutition 102, 103

Pick disease 298, 299

spinal artery syndrome 282

direct 210

Pineal region tumors 258, 259

Parinaud syndrome 70, 92, 358

facial nerve 96

Pineoblastoma 258, 377

Parkinson disease 62, 206–213

gustatory 78

Pineocytoma 258, 377

agraphia 128

indirect 210

“Pisa” syndrome 65, 66

autonomic dysfunction 208,

limbic system 144

Pituitary gland 6

209

olfactory 76

anterior lobe 142

bladder disorders 208, 371

pain 104, 109

hypothalamic–pituitary reg-

blood pressure changes

pupillomotor 90

ulatory axis 367

208

somatosensory 104

posterior lobe 142

constipation 208

visual 80–81

Sheehan’s postpartum

hyperhidrosis 208

Peduncle, cerebellar

necrosis 258

leg edema 208

inferior 54

stalk 6

seborrhea 208

lesions 358

tumors

sexual dysfunction 208

middle 54

adenoma 258, 259, 377

sleep disorders 208, 209

superior 54

metastases 262

behavioral changes 206–209

Pelizaeus–Merzbacher disease

treatment 264

anxiety 206

387

Plasmodium falciparum (cere-

dementia 208

Penicillin 230

bral malaria) 250, 251

depression 206

Peregrinating patient 138

Platybasia 292, 293

hallucinations 208

Pergolide 212

Plexopathy 50, 318, 321

cardinal manifestations 206,

Pericranium 4, 6

Plexus(es) 32–36

207

Perineurium 2, 30

brachial 32, 34, 318

akinesia 206

Peripheral nervous system

infraclavicular region 318

bradykinesia 206

(PNS) 2, 3

Pancoast tumor 262

hypokinesia 206

Peristalsis 154

plexopathy 318, 321, 393

postural instability 206,

Peritonitis 226

supraclavicular region 318

207

Perlia’s nucleus 90

trauma 272, 330

rigidity 206, 207

Perphenazine 204

cervical 32, 35

tremor 206, 207

Perseveration 126

cervicobrachial 34

dystonia 208, 209

Persistent somatoform pain

choroid 6, 8

genetics of 213

disorder 138, 139

carcinoma 377

idiopathic 302

Persistent vegetative state 120,

papilloma 256, 257, 377

pathogenesis 210–211

121

coccygeal 32

basal ganglia 210, 211

Personality 122

ganglionic, submucous 154

connections 210, 211

Phakomatoses 294–295, 381

lumbar 32, 36

motor function 210

Phencyclidine (PCP) abuse 314

lumbosacral 36

neurotransmitters 210

Phenobarbital 198

plexopathy 318, 321, 393

sensory manifestations 208

Phenomenon

myenteric 154

dysesthesias 208

black-curtain 168

pterygoid 20

pain 208, 209

doll’s-eye 26, 302, 303

sacral 32

treatment 212–213

coma and 118

lesions 318

deep brain stimulation 212

extinction 132

vertebral venous

neuroprotective 212

rebound 276, 277

external 22

 

 

internal 22

Rohkamm, Color Atlas of Neurology © 2004 Thieme

All rights reserved. Usage subject to terms and conditions of license.

Соседние файлы в предмете Нормальная анатомия